Who owns the XIVVOET trademark?

The live mark is owned by Novartis AG.

What classes is XIVVOET trademarked in?

The live marks are in class 5 (Pharmaceuticals).

What should I do if I want to use XIVVOET?

Screen the name for your goods first — a live mark in your class is the blocking case — and get a trademark attorney's view before investing in branding. This page is a screen, not a clearance opinion.

Is it trademarked?

Is XIVVOET trademarked?

Yes — XIVVOET is a live registered trademark. 1 live mark with the exact name XIVVOET, owned by Novartis AG, in class 5.

Live marks with the exact name

Exact wordmark matches in the USPTO federal register, newest filing first.

XIVVOETLive · Registered

Serial 79450897 · REGISTERED · Classes 5 (Pharmaceuticals) · Owner Novartis AG · Filed 2026-03-24 · Registered 2026-08-25

Register data indexed 2026-11-06. Bulk records trail live filings — check the official USPTO search for the latest status before filing.

What this means

The live mark sits in class 5 (Pharmaceuticals). A live mark in one class is a problem mainly if you sell in that class or a related one — the same word can often coexist in an unrelated class. Check whether any live mark overlaps the classes you sell in.

Classes with a live mark: Class 5 (Pharmaceuticals)

Screen your own name

A fast first-pass screen against the USPTO federal register — sound-alikes, look-alikes, and same or related classes, in plain English. Free, no signup.

This is a screen, not a clearance opinion — common-law, state, and very recent filings are not covered.

Frequently asked questions

Is XIVVOET trademarked?: Yes — there is 1 live mark with the exact name XIVVOET, and it is registered.
Who owns the XIVVOET trademark?: The live mark is owned by Novartis AG.
What classes is XIVVOET trademarked in?: The live marks are in class 5 (Pharmaceuticals).
What should I do if I want to use XIVVOET?: Screen the name for your goods first — a live mark in your class is the blocking case — and get a trademark attorney's view before investing in branding. This page is a screen, not a clearance opinion.